2014•Clinical Lung CancerRequires access

Concentrations of Erlotinib in Tumor Tissue and Plasma in Non–Small-Cell Lung Cancer Patients After Neoadjuvant Therapy

Nienke A. G. Lankheet, Eva E. Schaake, Sjaak A. Burgers, Renée van Pel, Jos H. Beijnen, Alwin D. R. Huitema, Houke M. Klomp

Open publisher page 24 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 24 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Erlotinib, Medicine, Erlotinib Hydrochloride, Lung cancer, Epidermal growth factor receptor, Internal medicine, Lung, Oncology

Back to paper search Browse research topics Original source

Concentrations of Erlotinib in Tumor Tissue and Plasma in Non–Small-Cell Lung Cancer Patients After Neoadjuvant Therapy — Research Paper | ScholarLens